Autoimmune diseases Thesis Topics

Autoimmune Diseases Thesis Topics

These autoimmune diseases thesis topics are intended for MD Medicine and DNB Medicine candidates studying rheumatoid arthritis, systemic lupus erythematosus, autoimmune thyroid disease, Sjögren syndrome, systemic sclerosis, idiopathic inflammatory myopathies, antineutrophil cytoplasmic antibody-associated vasculitis, autoimmune hepatitis, antiphospholipid syndrome and mixed connective tissue disease. The emphasis is on designs that can be completed within one thesis period using patients, structured clinical examination, validated activity and functional scales, routine laboratory investigations, autoantibody testing and clinically indicated imaging or organ-function assessment. Strong projects separate disease activity from accumulated damage and treatment effects, define organ involvement objectively and avoid testing a laboratory variable against a composite activity score that already contains that variable. The same framework can be adapted for autoimmune disease research topics, an MD Medicine autoimmune disease protocol or a DNB Medicine autoimmune disease synopsis before final discussion with the postgraduate guide.

Last reviewed and updated: September 2026 · 2026–27 admissions

Our MD Medicine Thesis Guidance provides structured protocols, sample size formulas, and institutional review board (IRB) layout guides.

Rheumatoid Arthritis

  1. Clinical and sociodemographic profile of adults with rheumatoid arthritis attending a tertiary care hospital: a hospital-based cross-sectional observational study.
  2. Pattern of joint involvement among adults with rheumatoid arthritis: a cross-sectional observational study.
  3. Association of duration of rheumatoid arthritis with current disease activity: an analytical cross-sectional study.
  4. Relationship between age at disease onset and current disease activity in rheumatoid arthritis: a hospital-based cross-sectional study.
  5. Comparison of clinical manifestations of rheumatoid arthritis in younger and older adults: a comparative cross-sectional study.
  6. Gender differences in clinical manifestations and disease activity among patients with rheumatoid arthritis: a comparative cross-sectional study.
  7. Association of body mass index with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  8. Relationship between central obesity and disease activity among adults with rheumatoid arthritis: a cross-sectional analytical study.
  9. Prevalence of overweight and obesity among patients with rheumatoid arthritis and their association with disease activity: a hospital-based cross-sectional study.
  10. Association of smoking status with disease activity among adults with rheumatoid arthritis: an analytical cross-sectional study.
  11. Relationship between tobacco chewing and disease activity in rheumatoid arthritis: a hospital-based cross-sectional study.
  12. Association of physical activity level with disease activity among patients with rheumatoid arthritis: a cross-sectional analytical study.
  13. Relationship between sedentary behaviour and functional limitation in rheumatoid arthritis: a hospital-based cross-sectional study.
  14. Association of sleep quality with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  15. Relationship between fatigue severity and disease activity among patients with rheumatoid arthritis: a cross-sectional observational study.
  16. Prevalence and severity of fatigue among adults with rheumatoid arthritis: a hospital-based cross-sectional observational study.
  17. Association of fatigue with haemoglobin concentration and inflammatory markers in rheumatoid arthritis: an analytical cross-sectional study.
  18. Prevalence and pattern of anaemia among adults with rheumatoid arthritis: a hospital-based cross-sectional observational study.
  19. Comparison of disease activity between rheumatoid arthritis patients with and without anaemia: a comparative cross-sectional study.
  20. Association of haemoglobin concentration with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  21. Relationship between red blood cell distribution width and disease activity among patients with rheumatoid arthritis: a cross-sectional analytical study.
  22. Association of platelet count with disease activity in rheumatoid arthritis: a hospital-based cross-sectional study.
  23. Relationship between mean platelet volume and disease activity among adults with rheumatoid arthritis: an analytical cross-sectional study.
  24. Association of neutrophil-to-lymphocyte ratio with disease activity in rheumatoid arthritis: a cross-sectional analytical study.
  25. Relationship between platelet-to-lymphocyte ratio and disease activity among patients with rheumatoid arthritis: a hospital-based cross-sectional study.
  26. Comparison of inflammatory blood cell indices among patients with low and high rheumatoid arthritis disease activity: a comparative cross-sectional study.
  27. Association of erythrocyte sedimentation rate with clinical disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  28. Relationship between C-reactive protein concentration and tender and swollen joint counts in rheumatoid arthritis: a hospital-based cross-sectional study.
  29. Comparison of erythrocyte sedimentation rate and C-reactive protein with clinical disease activity in rheumatoid arthritis: a comparative cross-sectional study.
  30. Association of rheumatoid factor positivity with clinical severity in rheumatoid arthritis: an analytical cross-sectional study.
  31. Comparison of clinical manifestations between rheumatoid factor positive and rheumatoid factor negative rheumatoid arthritis: a comparative cross-sectional study.
  32. Association of anti-cyclic citrullinated peptide antibody positivity with disease activity in rheumatoid arthritis: a cross-sectional analytical study.
  33. Comparison of clinical characteristics of anti-cyclic citrullinated peptide antibody positive and negative rheumatoid arthritis: a comparative cross-sectional study.
  34. Relationship between rheumatoid factor titre and current disease activity in rheumatoid arthritis: a hospital-based cross-sectional study.
  35. Association of anti-cyclic citrullinated peptide antibody titre with joint deformities in rheumatoid arthritis: an analytical cross-sectional study.
  36. Prevalence and pattern of joint deformities among adults with established rheumatoid arthritis: a cross-sectional observational study.
  37. Association of joint deformities with functional disability in rheumatoid arthritis: an analytical cross-sectional study.
  38. Comparison of functional status between rheumatoid arthritis patients with and without hand deformities: a comparative cross-sectional study.
  39. Pattern of hand and wrist involvement in rheumatoid arthritis and its association with functional limitation: a hospital-based cross-sectional study.
  40. Association of grip strength with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  41. Comparison of hand grip strength in patients with low and high rheumatoid arthritis disease activity: a comparative cross-sectional study.
  42. Relationship between morning stiffness duration and disease activity in rheumatoid arthritis: a cross-sectional analytical study.
  43. Association of pain severity with functional disability among patients with rheumatoid arthritis: an analytical cross-sectional study.
  44. Relationship between patient-reported pain score and inflammatory markers in rheumatoid arthritis: a hospital-based cross-sectional study.
  45. Prevalence of functional disability among patients with rheumatoid arthritis and its associated factors: a cross-sectional observational study.
  46. Association of Health Assessment Questionnaire disability score with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  47. Comparison of functional disability between early and established rheumatoid arthritis: a comparative cross-sectional study.
  48. Association of disease duration with functional disability among adults with rheumatoid arthritis: a hospital-based cross-sectional study.
  49. Relationship between educational status and functional disability in rheumatoid arthritis: an analytical cross-sectional study.
  50. Association of employment status with functional limitation among adults with rheumatoid arthritis: a cross-sectional analytical study.
  51. Work productivity impairment among employed patients with rheumatoid arthritis and its association with disease activity: a cross-sectional observational study.
  52. Comparison of disease activity and disability among manual and non-manual workers with rheumatoid arthritis: a comparative cross-sectional study.
  53. Health-related quality of life among adults with rheumatoid arthritis and its association with disease activity: a hospital-based cross-sectional study.
  54. Association of functional disability with health-related quality of life in rheumatoid arthritis: an analytical cross-sectional study.
  55. Comparison of quality of life between patients with low and high rheumatoid arthritis disease activity: a comparative cross-sectional study.
  56. Prevalence of depressive symptoms among adults with rheumatoid arthritis and their association with disease activity: a cross-sectional observational study.
  57. Association of anxiety symptoms with disease activity among patients with rheumatoid arthritis: an analytical cross-sectional study.
  58. Relationship between depressive symptoms and functional disability in rheumatoid arthritis: a hospital-based cross-sectional study.
  59. Comparison of sleep quality between rheumatoid arthritis patients with and without depressive symptoms: a comparative cross-sectional study.
  60. Prevalence of vitamin D deficiency among adults with rheumatoid arthritis: a cross-sectional observational study.
  61. Association of serum vitamin D concentration with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  62. Comparison of disease activity between vitamin D deficient and vitamin D sufficient patients with rheumatoid arthritis: a comparative cross-sectional study.
  63. Relationship between serum calcium concentration and disease activity among adults with rheumatoid arthritis: a hospital-based cross-sectional study.
  64. Prevalence of low bone mineral density among adults with rheumatoid arthritis: a hospital-based cross-sectional observational study.
  65. Association of disease activity with low bone mineral density in rheumatoid arthritis: an analytical cross-sectional study.
  66. Comparison of bone mineral density between patients receiving and not receiving long-term glucocorticoid therapy for rheumatoid arthritis: a comparative cross-sectional study.
  67. Association of cumulative self-reported glucocorticoid exposure with low bone mineral density in rheumatoid arthritis: a cross-sectional analytical study.
  68. Prevalence of vertebral fracture risk factors among adults with rheumatoid arthritis: a hospital-based cross-sectional observational study.
  69. Cardiovascular risk factor profile among adults with rheumatoid arthritis: a cross-sectional observational study.
  70. Prevalence of hypertension among patients with rheumatoid arthritis and its association with disease activity: a hospital-based cross-sectional study.
  71. Association of metabolic syndrome with disease activity among adults with rheumatoid arthritis: an analytical cross-sectional study.
  72. Comparison of metabolic syndrome prevalence in rheumatoid arthritis patients with low and high disease activity: a comparative cross-sectional study.
  73. Lipid profile abnormalities among adults with rheumatoid arthritis: a cross-sectional observational study.
  74. Association of high-density lipoprotein cholesterol with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  75. Relationship between triglyceride concentration and disease activity among patients with rheumatoid arthritis: a hospital-based cross-sectional study.
  76. Prevalence of insulin resistance markers among adults with rheumatoid arthritis and their association with disease activity: a cross-sectional analytical study.
  77. Association of fasting blood glucose with disease activity in rheumatoid arthritis: a hospital-based cross-sectional study.
  78. Prevalence of thyroid dysfunction among adults with rheumatoid arthritis: a cross-sectional observational study.
  79. Comparison of disease activity in rheumatoid arthritis patients with and without thyroid dysfunction: a comparative cross-sectional study.
  80. Association of autoimmune thyroid disease with rheumatoid arthritis disease characteristics: a hospital-based cross-sectional study.
  81. Renal function abnormalities among adults with rheumatoid arthritis: a cross-sectional observational study.
  82. Association of estimated glomerular filtration rate with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  83. Prevalence of proteinuria among adults with rheumatoid arthritis and its clinical correlates: a hospital-based cross-sectional study.
  84. Liver function abnormalities among adults with rheumatoid arthritis receiving disease-modifying antirheumatic drugs: a cross-sectional observational study.
  85. Comparison of liver enzyme abnormalities among patients receiving different conventional disease-modifying antirheumatic drug regimens for rheumatoid arthritis: a comparative cross-sectional study.
  86. Association of methotrexate use with current liver enzyme abnormalities in rheumatoid arthritis: an analytical cross-sectional study.
  87. Prevalence of gastrointestinal symptoms among adults receiving methotrexate for rheumatoid arthritis: a cross-sectional observational study.
  88. Comparison of haematological abnormalities among rheumatoid arthritis patients receiving methotrexate alone and combination conventional therapy: a comparative cross-sectional study.
  89. Medication adherence among adults with rheumatoid arthritis and its association with current disease activity: a cross-sectional analytical study.
  90. Factors associated with poor medication adherence among patients with rheumatoid arthritis: a hospital-based cross-sectional study.
  91. Comparison of disease activity between patients with good and poor medication adherence in rheumatoid arthritis: a comparative cross-sectional study.
  92. Pattern of complementary and alternative medicine use among adults with rheumatoid arthritis: a cross-sectional observational study.
  93. Association of complementary medicine use with medication adherence among patients with rheumatoid arthritis: an analytical cross-sectional study.
  94. Prevalence and pattern of extra-articular manifestations in rheumatoid arthritis: a hospital-based cross-sectional observational study.
  95. Association of rheumatoid nodules with seropositivity and disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  96. Prevalence of sicca symptoms among adults with rheumatoid arthritis and their clinical correlates: a cross-sectional study.
  97. Prevalence of pulmonary symptoms among adults with rheumatoid arthritis and their association with disease characteristics: a hospital-based cross-sectional study.
  98. Comparison of rheumatoid arthritis disease characteristics in patients with and without respiratory symptoms: a comparative cross-sectional study.
  99. Prevalence of electrocardiographic abnormalities among adults with rheumatoid arthritis: a cross-sectional observational study.
  100. Association of corrected QT interval with disease activity and inflammatory markers in rheumatoid arthritis: an analytical cross-sectional study.
  101. Prevalence of peripheral neuropathic symptoms among adults with rheumatoid arthritis: a hospital-based cross-sectional observational study.
  102. Association of neuropathic pain features with disease activity in rheumatoid arthritis: an analytical cross-sectional study.
  103. Prevalence of carpal tunnel syndrome symptoms among adults with rheumatoid arthritis and associated clinical factors: a cross-sectional study.
  104. Comparison of clinical characteristics between rheumatoid arthritis patients with and without carpal tunnel syndrome: a comparative cross-sectional study.
  105. Nutritional status among adults with rheumatoid arthritis and its association with disease activity: a hospital-based cross-sectional study.
  106. Association of serum albumin concentration with disease activity and functional status in rheumatoid arthritis: an analytical cross-sectional study.
  107. Prevalence of sarcopenia risk among adults with rheumatoid arthritis using bedside screening tools: a cross-sectional observational study.
  108. Association of calf circumference and hand grip strength with functional disability in rheumatoid arthritis: an analytical cross-sectional study.
  109. Comparison of disease activity and functional status between rural and urban patients with rheumatoid arthritis: a comparative cross-sectional study.
  110. Clinical, laboratory and treatment profile of rheumatoid arthritis patients attending a tertiary care medicine outpatient department in India: a hospital-based cross-sectional observational study.

Systemic Lupus Erythematosus

  1. Clinical and sociodemographic profile of adults with systemic lupus erythematosus attending a tertiary care hospital: a cross-sectional observational study.
  2. Pattern of organ involvement among adults with systemic lupus erythematosus: a hospital-based cross-sectional observational study.
  3. Association of disease duration with current disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  4. Relationship between age at disease onset and current disease activity in systemic lupus erythematosus: a hospital-based cross-sectional study.
  5. Comparison of clinical manifestations of systemic lupus erythematosus in younger and older adults: a comparative cross-sectional study.
  6. Gender differences in clinical manifestations of systemic lupus erythematosus: a comparative cross-sectional study.
  7. Prevalence and pattern of constitutional symptoms in systemic lupus erythematosus: a cross-sectional observational study.
  8. Association of body mass index with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  9. Prevalence of undernutrition, overweight and obesity among adults with systemic lupus erythematosus: a hospital-based cross-sectional study.
  10. Association of sleep quality with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  11. Prevalence of fatigue among adults with systemic lupus erythematosus and its association with disease activity: a cross-sectional observational study.
  12. Relationship between fatigue severity and haemoglobin concentration in systemic lupus erythematosus: an analytical cross-sectional study.
  13. Prevalence and morphological pattern of anaemia in systemic lupus erythematosus: a hospital-based cross-sectional observational study.
  14. Association of anaemia with current disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  15. Comparison of disease activity between systemic lupus erythematosus patients with and without anaemia: a comparative cross-sectional study.
  16. Prevalence of leukopenia among adults with systemic lupus erythematosus and its association with clinical manifestations: a cross-sectional study.
  17. Association of lymphopenia with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  18. Prevalence and clinical correlates of thrombocytopenia in systemic lupus erythematosus: a hospital-based cross-sectional study.
  19. Comparison of clinical manifestations between patients with and without thrombocytopenia in systemic lupus erythematosus: a comparative cross-sectional study.
  20. Association of neutrophil-to-lymphocyte ratio with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  21. Relationship between platelet-to-lymphocyte ratio and disease activity in systemic lupus erythematosus: a hospital-based cross-sectional study.
  22. Association of red blood cell distribution width with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  23. Comparison of inflammatory blood cell indices among patients with low and high systemic lupus erythematosus disease activity: a comparative cross-sectional study.
  24. Association of erythrocyte sedimentation rate with current disease activity in systemic lupus erythematosus: a cross-sectional analytical study.
  25. Relationship between C-reactive protein concentration and infection-related clinical features in systemic lupus erythematosus: a hospital-based cross-sectional study.
  26. Comparison of erythrocyte sedimentation rate and C-reactive protein patterns in active and inactive systemic lupus erythematosus: a comparative cross-sectional study.
  27. Association of serum complement component three concentration with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  28. Association of serum complement component four concentration with disease activity in systemic lupus erythematosus: a cross-sectional analytical study.
  29. Comparison of complement concentrations in systemic lupus erythematosus patients with and without renal involvement: a comparative cross-sectional study.
  30. Association of anti-double-stranded deoxyribonucleic acid antibody titre with current disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  31. Relationship between anti-double-stranded deoxyribonucleic acid antibody positivity and renal involvement in systemic lupus erythematosus: a hospital-based cross-sectional study.
  32. Comparison of clinical manifestations between patients with high and low anti-double-stranded deoxyribonucleic acid antibody titres: a comparative cross-sectional study.
  33. Pattern of antinuclear antibody profiles among adults with systemic lupus erythematosus: a cross-sectional observational study.
  34. Association of extractable nuclear antigen antibody patterns with clinical manifestations of systemic lupus erythematosus: an analytical cross-sectional study.
  35. Prevalence and pattern of musculoskeletal manifestations in systemic lupus erythematosus: a hospital-based cross-sectional observational study.
  36. Association of musculoskeletal symptoms with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  37. Comparison of disease activity in patients with and without arthritis in systemic lupus erythematosus: a comparative cross-sectional study.
  38. Prevalence and pattern of mucocutaneous manifestations in systemic lupus erythematosus: a cross-sectional observational study.
  39. Association of photosensitivity with current disease activity in systemic lupus erythematosus: a hospital-based cross-sectional study.
  40. Relationship between oral ulcers and haematological abnormalities in systemic lupus erythematosus: an analytical cross-sectional study.
  41. Comparison of laboratory profiles of patients with and without active mucocutaneous manifestations of systemic lupus erythematosus: a comparative cross-sectional study.
  42. Prevalence and pattern of renal involvement in adults with systemic lupus erythematosus: a hospital-based cross-sectional observational study.
  43. Association of proteinuria with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  44. Relationship between urine protein-to-creatinine ratio and serum complement concentrations in systemic lupus erythematosus: a cross-sectional analytical study.
  45. Association of microscopic haematuria with immunological activity markers in systemic lupus erythematosus: a hospital-based cross-sectional study.
  46. Comparison of clinical and laboratory profiles of systemic lupus erythematosus patients with and without renal involvement: a comparative cross-sectional study.
  47. Association of estimated glomerular filtration rate with disease activity among patients with systemic lupus erythematosus: an analytical cross-sectional study.
  48. Relationship between serum albumin concentration and proteinuria in systemic lupus erythematosus: a cross-sectional analytical study.
  49. Prevalence of hypertension among systemic lupus erythematosus patients with renal involvement: a hospital-based cross-sectional study.
  50. Comparison of disease activity among hypertensive and normotensive patients with systemic lupus erythematosus: a comparative cross-sectional study.
  51. Prevalence and pattern of neurological manifestations among adults with systemic lupus erythematosus: a cross-sectional observational study.
  52. Association of headache with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  53. Prevalence of cognitive complaints among adults with systemic lupus erythematosus and associated clinical factors: a hospital-based cross-sectional study.
  54. Comparison of disease characteristics between systemic lupus erythematosus patients with and without neurological manifestations: a comparative cross-sectional study.
  55. Prevalence of depressive symptoms among adults with systemic lupus erythematosus: a cross-sectional observational study.
  56. Association of depressive symptoms with disease activity and functional limitation in systemic lupus erythematosus: an analytical cross-sectional study.
  57. Prevalence of anxiety symptoms among adults with systemic lupus erythematosus and associated factors: a hospital-based cross-sectional study.
  58. Comparison of quality of life among systemic lupus erythematosus patients with and without depressive symptoms: a comparative cross-sectional study.
  59. Health-related quality of life and its association with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  60. Relationship between fatigue, sleep quality and health-related quality of life in systemic lupus erythematosus: a hospital-based cross-sectional study.
  61. Prevalence of cardiovascular risk factors among adults with systemic lupus erythematosus: a cross-sectional observational study.
  62. Association of metabolic syndrome with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  63. Comparison of metabolic syndrome prevalence in patients receiving and not receiving glucocorticoids for systemic lupus erythematosus: a comparative cross-sectional study.
  64. Lipid profile abnormalities among adults with systemic lupus erythematosus: a hospital-based cross-sectional study.
  65. Association of dyslipidaemia with current disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  66. Prevalence of electrocardiographic abnormalities among adults with systemic lupus erythematosus: a cross-sectional observational study.
  67. Association of corrected QT interval with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  68. Prevalence of vitamin D deficiency among adults with systemic lupus erythematosus: a hospital-based cross-sectional observational study.
  69. Association of serum vitamin D concentration with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  70. Comparison of disease activity between vitamin D deficient and vitamin D sufficient systemic lupus erythematosus patients: a comparative cross-sectional study.
  71. Prevalence of low bone mineral density among adults with systemic lupus erythematosus: a cross-sectional observational study.
  72. Association of glucocorticoid exposure with low bone mineral density in systemic lupus erythematosus: an analytical cross-sectional study.
  73. Comparison of bone mineral density in premenopausal women with systemic lupus erythematosus receiving low and high cumulative glucocorticoid exposure: a comparative cross-sectional study.
  74. Prevalence of thyroid dysfunction among adults with systemic lupus erythematosus: a hospital-based cross-sectional study.
  75. Association of autoimmune thyroid disease with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  76. Comparison of systemic lupus erythematosus manifestations in patients with and without thyroid autoimmunity: a comparative cross-sectional study.
  77. Prevalence of liver enzyme abnormalities among adults with systemic lupus erythematosus: a cross-sectional observational study.
  78. Association of current immunosuppressive treatment pattern with liver enzyme abnormalities in systemic lupus erythematosus: an analytical cross-sectional study.
  79. Medication adherence among adults with systemic lupus erythematosus and its association with disease activity: a cross-sectional analytical study.
  80. Factors associated with poor medication adherence among patients with systemic lupus erythematosus: a hospital-based cross-sectional study.
  81. Comparison of disease activity between systemic lupus erythematosus patients with good and poor medication adherence: a comparative cross-sectional study.
  82. Pattern of complementary and alternative medicine use among adults with systemic lupus erythematosus: a cross-sectional observational study.
  83. Association of health literacy with medication adherence in systemic lupus erythematosus: an analytical cross-sectional study.
  84. Prevalence of menstrual irregularities among women with systemic lupus erythematosus and associated clinical factors: a cross-sectional study.
  85. Reproductive health concerns among women with systemic lupus erythematosus: a hospital-based cross-sectional observational study.
  86. Prevalence of antiphospholipid antibody positivity among adults with systemic lupus erythematosus: a cross-sectional observational study.
  87. Comparison of clinical manifestations between systemic lupus erythematosus patients with and without antiphospholipid antibody positivity: a comparative cross-sectional study.
  88. Association of antiphospholipid antibody positivity with thrombocytopenia in systemic lupus erythematosus: an analytical cross-sectional study.
  89. Prevalence of sicca symptoms among adults with systemic lupus erythematosus and associated disease characteristics: a cross-sectional observational study.
  90. Comparison of systemic lupus erythematosus patients with and without sicca symptoms with respect to clinical and immunological characteristics: a comparative cross-sectional study.
  91. Prevalence of respiratory symptoms among adults with systemic lupus erythematosus: a hospital-based cross-sectional study.
  92. Association of respiratory symptoms with disease activity in systemic lupus erythematosus: an analytical cross-sectional study.
  93. Prevalence of gastrointestinal symptoms among adults with systemic lupus erythematosus and their association with treatment pattern: a cross-sectional study.
  94. Nutritional status among adults with systemic lupus erythematosus and its association with disease activity: a hospital-based cross-sectional study.
  95. Association of serum albumin concentration with disease activity and nutritional status in systemic lupus erythematosus: an analytical cross-sectional study.
  96. Prevalence of sarcopenia risk among adults with systemic lupus erythematosus using bedside screening tools: a cross-sectional observational study.
  97. Association of hand grip strength with disease activity and functional status in systemic lupus erythematosus: an analytical cross-sectional study.
  98. Comparison of clinical characteristics of rural and urban patients with systemic lupus erythematosus: a comparative cross-sectional study.
  99. Association of socioeconomic status with disease activity and medication adherence in systemic lupus erythematosus: a cross-sectional analytical study.
  100. Clinical, laboratory and treatment profile of adults with systemic lupus erythematosus attending a medicine department in India: a hospital-based cross-sectional observational study.

Autoimmune Thyroid Disease

  1. Clinical and biochemical profile of adults with autoimmune hypothyroidism: a hospital-based cross-sectional observational study.
  2. Clinical profile of adults with autoimmune hyperthyroidism attending a tertiary care hospital: a cross-sectional observational study.
  3. Comparison of clinical characteristics of autoimmune hypothyroidism and autoimmune hyperthyroidism: a comparative cross-sectional study.
  4. Prevalence of thyroid peroxidase antibody positivity among adults with primary hypothyroidism: a hospital-based cross-sectional study.
  5. Association of thyroid peroxidase antibody titre with thyroid-stimulating hormone concentration in autoimmune hypothyroidism: an analytical cross-sectional study.
  6. Relationship between thyroglobulin antibody positivity and biochemical severity of hypothyroidism: a cross-sectional analytical study.
  7. Comparison of clinical manifestations in thyroid peroxidase antibody positive and antibody negative primary hypothyroidism: a comparative cross-sectional study.
  8. Association of age with thyroid autoantibody titres among adults with autoimmune thyroid disease: an analytical cross-sectional study.
  9. Gender differences in clinical and biochemical manifestations of autoimmune thyroid disease: a comparative cross-sectional study.
  10. Association of body mass index with thyroid-stimulating hormone concentration in autoimmune hypothyroidism: an analytical cross-sectional study.
  11. Comparison of obesity prevalence in adults with autoimmune and non-autoimmune primary hypothyroidism: a comparative cross-sectional study.
  12. Relationship between waist circumference and biochemical severity of autoimmune hypothyroidism: a hospital-based cross-sectional study.
  13. Prevalence of metabolic syndrome among adults with autoimmune hypothyroidism: a cross-sectional observational study.
  14. Association of thyroid-stimulating hormone concentration with components of metabolic syndrome in autoimmune hypothyroidism: an analytical cross-sectional study.
  15. Comparison of metabolic syndrome prevalence between euthyroid autoimmune thyroiditis and overt autoimmune hypothyroidism: a comparative cross-sectional study.
  16. Lipid profile abnormalities among adults with autoimmune hypothyroidism: a hospital-based cross-sectional observational study.
  17. Association of thyroid-stimulating hormone concentration with low-density lipoprotein cholesterol in autoimmune hypothyroidism: an analytical cross-sectional study.
  18. Relationship between thyroid peroxidase antibody titre and lipid profile abnormalities in autoimmune thyroid disease: a cross-sectional analytical study.
  19. Comparison of lipid profiles between subclinical and overt autoimmune hypothyroidism: a comparative cross-sectional study.
  20. Association of triglyceride concentration with biochemical severity of hypothyroidism: a hospital-based cross-sectional study.
  21. Prevalence of dysglycemia among adults with autoimmune thyroid disease: a cross-sectional observational study.
  22. Association of fasting blood glucose with thyroid function parameters in autoimmune hypothyroidism: an analytical cross-sectional study.
  23. Comparison of glycaemic parameters between adults with autoimmune hypothyroidism and autoimmune hyperthyroidism: a comparative cross-sectional study.
  24. Prevalence and pattern of anaemia among adults with autoimmune hypothyroidism: a hospital-based cross-sectional study.
  25. Association of haemoglobin concentration with thyroid-stimulating hormone levels in autoimmune hypothyroidism: an analytical cross-sectional study.
  26. Comparison of haematological parameters between subclinical and overt autoimmune hypothyroidism: a comparative cross-sectional study.
  27. Relationship between mean corpuscular volume and biochemical severity of autoimmune hypothyroidism: a cross-sectional analytical study.
  28. Prevalence of iron deficiency among women with autoimmune hypothyroidism: a hospital-based cross-sectional observational study.
  29. Association of serum ferritin concentration with thyroid function parameters in women with autoimmune hypothyroidism: an analytical cross-sectional study.
  30. Prevalence of vitamin B12 deficiency among adults with autoimmune thyroid disease: a cross-sectional observational study.
  31. Association of vitamin B12 deficiency with thyroid autoantibody positivity in autoimmune hypothyroidism: an analytical cross-sectional study.
  32. Comparison of vitamin B12 status between adults with autoimmune and non-autoimmune hypothyroidism: a comparative cross-sectional study.
  33. Prevalence of vitamin D deficiency among adults with autoimmune thyroid disease: a hospital-based cross-sectional observational study.
  34. Association of serum vitamin D concentration with thyroid peroxidase antibody titre: an analytical cross-sectional study.
  35. Comparison of vitamin D status between thyroid peroxidase antibody positive and antibody negative hypothyroidism: a comparative cross-sectional study.
  36. Association of serum calcium concentration with thyroid function in autoimmune hypothyroidism: a hospital-based cross-sectional study.
  37. Electrolyte abnormalities among adults with severe autoimmune hypothyroidism: a cross-sectional observational study.
  38. Association of serum sodium concentration with thyroid-stimulating hormone in autoimmune hypothyroidism: an analytical cross-sectional study.
  39. Liver enzyme abnormalities among adults with autoimmune thyroid disease: a hospital-based cross-sectional study.
  40. Comparison of liver function parameters between autoimmune hypothyroidism and autoimmune hyperthyroidism: a comparative cross-sectional study.
  41. Renal function parameters in adults with autoimmune hypothyroidism and their association with thyroid function: an analytical cross-sectional study.
  42. Comparison of estimated glomerular filtration rate between subclinical and overt autoimmune hypothyroidism: a comparative cross-sectional study.
  43. Prevalence of hypertension among adults with autoimmune hypothyroidism: a cross-sectional observational study.
  44. Association of blood pressure with thyroid-stimulating hormone concentration in autoimmune hypothyroidism: an analytical cross-sectional study.
  45. Pulse pressure and heart rate patterns among adults with autoimmune hyperthyroidism: a hospital-based cross-sectional study.
  46. Electrocardiographic abnormalities among adults with autoimmune hypothyroidism: a cross-sectional observational study.
  47. Association of corrected QT interval with thyroid-stimulating hormone concentration in autoimmune hypothyroidism: an analytical cross-sectional study.
  48. Electrocardiographic abnormalities among adults with autoimmune hyperthyroidism: a hospital-based cross-sectional observational study.
  49. Comparison of electrocardiographic findings between autoimmune hypothyroidism and autoimmune hyperthyroidism: a comparative cross-sectional study.
  50. Prevalence of atrial fibrillation among adults with autoimmune hyperthyroidism and associated clinical factors: a cross-sectional study.
  51. Association of resting heart rate with free thyroxine concentration in autoimmune hyperthyroidism: an analytical cross-sectional study.
  52. Prevalence of tremor among adults with autoimmune hyperthyroidism and its association with biochemical severity: a cross-sectional study.
  53. Pattern of neuropsychiatric symptoms among adults with autoimmune thyroid disease: a hospital-based cross-sectional observational study.
  54. Association of depressive symptoms with biochemical severity of autoimmune hypothyroidism: an analytical cross-sectional study.
  55. Prevalence of anxiety symptoms among adults with autoimmune hyperthyroidism: a cross-sectional observational study.
  56. Comparison of anxiety and depressive symptoms between autoimmune hypothyroidism and autoimmune hyperthyroidism: a comparative cross-sectional study.
  57. Association of sleep quality with thyroid function parameters in autoimmune thyroid disease: an analytical cross-sectional study.
  58. Fatigue severity among adults with autoimmune hypothyroidism and its relationship with thyroid-stimulating hormone concentration: a cross-sectional analytical study.
  59. Health-related quality of life among adults with autoimmune hypothyroidism and associated factors: a hospital-based cross-sectional study.
  60. Comparison of quality of life between subclinical and overt autoimmune hypothyroidism: a comparative cross-sectional study.
  61. Menstrual abnormalities among reproductive-age women with autoimmune hypothyroidism: a cross-sectional observational study.
  62. Association of menstrual irregularity with biochemical severity of autoimmune hypothyroidism: an analytical cross-sectional study.
  63. Comparison of thyroid function parameters among women with and without menstrual irregularities in autoimmune thyroid disease: a comparative cross-sectional study.
  64. Prevalence of goitre among adults with autoimmune thyroid disease and its clinical correlates: a hospital-based cross-sectional study.
  65. Association of thyroid gland size on ultrasonography with thyroid autoantibody titres in autoimmune thyroiditis: an analytical cross-sectional study.
  66. Comparison of ultrasonographic thyroid patterns in antibody positive and antibody negative primary hypothyroidism: a comparative cross-sectional study.
  67. Association of thyroid ultrasonographic echogenicity with thyroid peroxidase antibody titre: a cross-sectional analytical study.
  68. Prevalence of ophthalmic manifestations among adults with autoimmune hyperthyroidism: a hospital-based cross-sectional observational study.
  69. Association of smoking with ophthalmic manifestations in autoimmune hyperthyroidism: an analytical cross-sectional study.
  70. Comparison of clinical and biochemical characteristics of autoimmune hyperthyroidism with and without ophthalmic manifestations: a comparative cross-sectional study.
  71. Prevalence of other autoimmune disorders among adults with autoimmune thyroid disease: a cross-sectional observational study.
  72. Association of autoimmune thyroid disease with rheumatoid arthritis among patients attending general medicine clinics: a hospital-based cross-sectional study.
  73. Prevalence of thyroid autoimmunity among adults with type 1 diabetes mellitus: a cross-sectional observational study.
  74. Comparison of glycaemic control in type 1 diabetes mellitus patients with and without autoimmune thyroid disease: a comparative cross-sectional study.
  75. Prevalence of thyroid autoimmunity among adults with systemic lupus erythematosus: a hospital-based cross-sectional study.
  76. Medication adherence among adults receiving levothyroxine for autoimmune hypothyroidism and associated factors: a cross-sectional analytical study.
  77. Association of levothyroxine adherence with thyroid-stimulating hormone control in autoimmune hypothyroidism: an analytical cross-sectional study.
  78. Comparison of thyroid-stimulating hormone concentrations between patients with good and poor levothyroxine adherence: a comparative cross-sectional study.
  79. Knowledge regarding levothyroxine administration among adults with autoimmune hypothyroidism: a cross-sectional observational study.
  80. Clinical, biochemical and treatment profile of autoimmune thyroid disease in adults attending a tertiary care medicine department: a hospital-based cross-sectional observational study.

Sjögren Syndrome

  1. Clinical and sociodemographic profile of adults with Sjögren syndrome: a hospital-based cross-sectional observational study.
  2. Pattern of glandular and extraglandular manifestations among adults with Sjögren syndrome: a cross-sectional observational study.
  3. Prevalence and severity of dry mouth symptoms among adults with Sjögren syndrome: a hospital-based cross-sectional study.
  4. Prevalence and severity of dry eye symptoms among adults with Sjögren syndrome: a cross-sectional observational study.
  5. Association of dry mouth severity with disease duration in Sjögren syndrome: an analytical cross-sectional study.
  6. Relationship between dry eye symptom severity and systemic disease activity in Sjögren syndrome: a cross-sectional analytical study.
  7. Comparison of clinical manifestations between primary and secondary Sjögren syndrome: a comparative cross-sectional study.
  8. Comparison of glandular manifestations in Sjögren syndrome associated with rheumatoid arthritis and systemic lupus erythematosus: a comparative cross-sectional study.
  9. Association of age with severity of sicca symptoms in Sjögren syndrome: an analytical cross-sectional study.
  10. Gender differences in clinical manifestations of Sjögren syndrome: a comparative cross-sectional study.
  11. Association of body mass index with fatigue severity in Sjögren syndrome: an analytical cross-sectional study.
  12. Prevalence of fatigue among adults with Sjögren syndrome and associated clinical factors: a cross-sectional observational study.
  13. Relationship between fatigue and disease activity in Sjögren syndrome: an analytical cross-sectional study.
  14. Association of sleep quality with fatigue among adults with Sjögren syndrome: a hospital-based cross-sectional study.
  15. Prevalence of depressive symptoms among adults with Sjögren syndrome: a cross-sectional observational study.
  16. Association of depressive symptoms with sicca severity and fatigue in Sjögren syndrome: an analytical cross-sectional study.
  17. Health-related quality of life among adults with Sjögren syndrome and associated factors: a hospital-based cross-sectional study.
  18. Comparison of quality of life between Sjögren syndrome patients with mild and severe sicca symptoms: a comparative cross-sectional study.
  19. Prevalence and pattern of anaemia among adults with Sjögren syndrome: a cross-sectional observational study.
  20. Association of haemoglobin concentration with fatigue in Sjögren syndrome: an analytical cross-sectional study.
  21. Prevalence of leukopenia among adults with Sjögren syndrome and its clinical correlates: a hospital-based cross-sectional study.
  22. Association of lymphopenia with systemic manifestations in Sjögren syndrome: an analytical cross-sectional study.
  23. Relationship between erythrocyte sedimentation rate and disease activity in Sjögren syndrome: a cross-sectional analytical study.
  24. Association of C-reactive protein concentration with extraglandular manifestations in Sjögren syndrome: a hospital-based cross-sectional study.
  25. Pattern of antinuclear antibody positivity among adults with Sjögren syndrome: a cross-sectional observational study.
  26. Association of anti-Ro antibody positivity with systemic manifestations in Sjögren syndrome: an analytical cross-sectional study.
  27. Association of anti-La antibody positivity with glandular manifestations in Sjögren syndrome: a cross-sectional analytical study.
  28. Comparison of clinical manifestations between anti-Ro antibody positive and negative Sjögren syndrome: a comparative cross-sectional study.
  29. Relationship between rheumatoid factor positivity and extraglandular manifestations in Sjögren syndrome: a hospital-based cross-sectional study.
  30. Prevalence of low complement concentrations among adults with Sjögren syndrome and associated clinical features: a cross-sectional study.
  31. Prevalence of musculoskeletal manifestations among adults with Sjögren syndrome: a hospital-based cross-sectional observational study.
  32. Association of arthralgia with inflammatory markers in Sjögren syndrome: an analytical cross-sectional study.
  33. Comparison of disease characteristics between Sjögren syndrome patients with and without arthritis: a comparative cross-sectional study.
  34. Prevalence of cutaneous manifestations among adults with Sjögren syndrome: a cross-sectional observational study.
  35. Association of purpuric skin lesions with immunological abnormalities in Sjögren syndrome: an analytical cross-sectional study.
  36. Prevalence of respiratory symptoms among adults with Sjögren syndrome: a hospital-based cross-sectional study.
  37. Association of respiratory symptoms with disease duration in Sjögren syndrome: an analytical cross-sectional study.
  38. Comparison of clinical profiles of Sjögren syndrome patients with and without respiratory manifestations: a comparative cross-sectional study.
  39. Prevalence of peripheral neuropathic symptoms among adults with Sjögren syndrome: a cross-sectional observational study.
  40. Association of neuropathic symptoms with systemic disease activity in Sjögren syndrome: an analytical cross-sectional study.
  41. Prevalence of renal abnormalities among adults with Sjögren syndrome: a hospital-based cross-sectional study.
  42. Association of urinary abnormalities with systemic manifestations in Sjögren syndrome: an analytical cross-sectional study.
  43. Prevalence of electrolyte abnormalities among adults with Sjögren syndrome and renal involvement: a cross-sectional observational study.
  44. Association of serum potassium concentration with renal manifestations in Sjögren syndrome: an analytical cross-sectional study.
  45. Prevalence of thyroid dysfunction among adults with Sjögren syndrome: a hospital-based cross-sectional study.
  46. Comparison of clinical characteristics of Sjögren syndrome patients with and without autoimmune thyroid disease: a comparative cross-sectional study.
  47. Prevalence of vitamin D deficiency among adults with Sjögren syndrome: a cross-sectional observational study.
  48. Association of serum vitamin D concentration with fatigue and disease activity in Sjögren syndrome: an analytical cross-sectional study.
  49. Nutritional status among adults with Sjögren syndrome and its association with dry mouth severity: a hospital-based cross-sectional study.
  50. Prevalence of dental complaints among adults with Sjögren syndrome and their relationship with dry mouth severity: a cross-sectional study.
  51. Association of unstimulated salivary flow rate with patient-reported dry mouth symptoms in Sjögren syndrome: an analytical cross-sectional study.
  52. Comparison of dry mouth severity among Sjögren syndrome patients with and without dental caries: a comparative cross-sectional study.
  53. Association of Schirmer test findings with patient-reported dry eye severity in Sjögren syndrome: an analytical cross-sectional study.
  54. Medication use pattern and current symptom burden among adults with Sjögren syndrome: a cross-sectional observational study.
  55. Clinical, laboratory and treatment profile of Sjögren syndrome in adults attending a tertiary care hospital: a hospital-based cross-sectional observational study.

Systemic Sclerosis

  1. Clinical and sociodemographic profile of adults with systemic sclerosis: a hospital-based cross-sectional observational study.
  2. Pattern of organ involvement among adults with systemic sclerosis: a cross-sectional observational study.
  3. Comparison of clinical manifestations between limited cutaneous and diffuse cutaneous systemic sclerosis: a comparative cross-sectional study.
  4. Association of disease duration with current organ involvement in systemic sclerosis: an analytical cross-sectional study.
  5. Relationship between age at disease onset and current clinical phenotype in systemic sclerosis: a hospital-based cross-sectional study.
  6. Gender differences in clinical manifestations of systemic sclerosis: a comparative cross-sectional study.
  7. Prevalence and severity of Raynaud phenomenon among adults with systemic sclerosis: a cross-sectional observational study.
  8. Association of Raynaud phenomenon severity with digital ulceration in systemic sclerosis: an analytical cross-sectional study.
  9. Comparison of clinical characteristics between systemic sclerosis patients with and without digital ulcers: a comparative cross-sectional study.
  10. Prevalence of digital pitting scars among adults with systemic sclerosis and associated clinical factors: a cross-sectional study.
  11. Association of modified skin thickness score with disease duration in systemic sclerosis: an analytical cross-sectional study.
  12. Relationship between skin thickness and functional limitation among adults with systemic sclerosis: a hospital-based cross-sectional study.
  13. Comparison of skin involvement between limited cutaneous and diffuse cutaneous systemic sclerosis: a comparative cross-sectional study.
  14. Prevalence of hand contractures among adults with systemic sclerosis: a cross-sectional observational study.
  15. Association of hand contractures with functional disability in systemic sclerosis: an analytical cross-sectional study.
  16. Prevalence of calcinosis among adults with systemic sclerosis and associated disease characteristics: a hospital-based cross-sectional study.
  17. Association of telangiectasia with clinical phenotype in systemic sclerosis: an analytical cross-sectional study.
  18. Prevalence of gastrointestinal symptoms among adults with systemic sclerosis: a cross-sectional observational study.
  19. Association of gastroesophageal reflux symptoms with disease subtype in systemic sclerosis: an analytical cross-sectional study.
  20. Comparison of gastrointestinal symptom burden between limited and diffuse systemic sclerosis: a comparative cross-sectional study.
  21. Association of dysphagia with nutritional status in systemic sclerosis: an analytical cross-sectional study.
  22. Prevalence of undernutrition among adults with systemic sclerosis and associated factors: a hospital-based cross-sectional study.
  23. Association of body mass index with gastrointestinal symptom burden in systemic sclerosis: an analytical cross-sectional study.
  24. Prevalence of anaemia among adults with systemic sclerosis: a cross-sectional observational study.
  25. Association of haemoglobin concentration with functional status in systemic sclerosis: an analytical cross-sectional study.
  26. Relationship between red blood cell distribution width and disease severity in systemic sclerosis: a hospital-based cross-sectional study.
  27. Association of erythrocyte sedimentation rate with systemic manifestations in systemic sclerosis: an analytical cross-sectional study.
  28. Prevalence of respiratory symptoms among adults with systemic sclerosis: a cross-sectional observational study.
  29. Association of exertional dyspnoea with clinical subtype in systemic sclerosis: an analytical cross-sectional study.
  30. Comparison of respiratory symptoms between limited and diffuse systemic sclerosis: a comparative cross-sectional study.
  31. Prevalence of restrictive spirometry pattern among adults with systemic sclerosis: a hospital-based cross-sectional study.
  32. Association of spirometric abnormalities with disease duration in systemic sclerosis: an analytical cross-sectional study.
  33. Comparison of spirometry findings in systemic sclerosis patients with and without respiratory symptoms: a comparative cross-sectional study.
  34. Association of resting oxygen saturation with respiratory symptom burden in systemic sclerosis: a hospital-based cross-sectional study.
  35. Prevalence of electrocardiographic abnormalities among adults with systemic sclerosis: a cross-sectional observational study.
  36. Association of electrocardiographic abnormalities with clinical subtype in systemic sclerosis: an analytical cross-sectional study.
  37. Prevalence of hypertension among adults with systemic sclerosis and associated clinical factors: a hospital-based cross-sectional study.
  38. Renal function abnormalities among adults with systemic sclerosis: a cross-sectional observational study.
  39. Association of estimated glomerular filtration rate with disease duration in systemic sclerosis: an analytical cross-sectional study.
  40. Prevalence of proteinuria among adults with systemic sclerosis and associated clinical factors: a hospital-based cross-sectional study.
  41. Pattern of antinuclear antibody profiles among adults with systemic sclerosis: a cross-sectional observational study.
  42. Association of anti-centromere antibody positivity with clinical manifestations of systemic sclerosis: an analytical cross-sectional study.
  43. Association of anti-topoisomerase one antibody positivity with diffuse cutaneous and respiratory manifestations in systemic sclerosis: an analytical cross-sectional study.
  44. Comparison of clinical manifestations between anti-centromere antibody positive and anti-topoisomerase one antibody positive systemic sclerosis: a comparative cross-sectional study.
  45. Prevalence of thyroid dysfunction among adults with systemic sclerosis: a hospital-based cross-sectional study.
  46. Association of autoimmune thyroid disease with systemic sclerosis phenotype: an analytical cross-sectional study.
  47. Prevalence of vitamin D deficiency among adults with systemic sclerosis: a cross-sectional observational study.
  48. Association of serum vitamin D concentration with skin thickness and functional status in systemic sclerosis: an analytical cross-sectional study.
  49. Prevalence of low bone mineral density among adults with systemic sclerosis: a hospital-based cross-sectional observational study.
  50. Association of nutritional status with low bone mineral density in systemic sclerosis: an analytical cross-sectional study.
  51. Prevalence of fatigue among adults with systemic sclerosis and associated clinical factors: a cross-sectional observational study.
  52. Association of fatigue with disease severity and haemoglobin concentration in systemic sclerosis: an analytical cross-sectional study.
  53. Prevalence of depressive symptoms among adults with systemic sclerosis: a hospital-based cross-sectional study.
  54. Association of depressive symptoms with functional limitation and quality of life in systemic sclerosis: an analytical cross-sectional study.
  55. Health-related quality of life among adults with systemic sclerosis and associated clinical factors: a cross-sectional study.

Idiopathic Inflammatory Myopathies

  1. Clinical and sociodemographic profile of adults with idiopathic inflammatory myopathies: a hospital-based cross-sectional observational study.
  2. Pattern of muscle and extramuscular manifestations among adults with idiopathic inflammatory myopathies: a cross-sectional observational study.
  3. Comparison of clinical manifestations between polymyositis and dermatomyositis: a comparative cross-sectional study.
  4. Association of disease duration with current muscle weakness in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  5. Relationship between age at disease onset and current clinical manifestations in idiopathic inflammatory myopathies: a hospital-based cross-sectional study.
  6. Gender differences in clinical manifestations of idiopathic inflammatory myopathies: a comparative cross-sectional study.
  7. Pattern of proximal muscle weakness among adults with idiopathic inflammatory myopathies: a cross-sectional observational study.
  8. Association of manual muscle strength assessment with serum creatine kinase concentration in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  9. Relationship between serum creatine kinase concentration and functional limitation in idiopathic inflammatory myopathies: a cross-sectional analytical study.
  10. Comparison of serum creatine kinase concentrations in polymyositis and dermatomyositis: a comparative cross-sectional study.
  11. Association of serum lactate dehydrogenase concentration with muscle weakness in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  12. Relationship between serum aspartate aminotransferase concentration and creatine kinase in idiopathic inflammatory myopathies: a hospital-based cross-sectional study.
  13. Comparison of muscle enzyme profiles in patients with mild and severe muscle weakness: a comparative cross-sectional study.
  14. Prevalence and pattern of skin manifestations among adults with dermatomyositis: a cross-sectional observational study.
  15. Association of skin manifestation burden with muscle enzyme elevation in dermatomyositis: an analytical cross-sectional study.
  16. Prevalence of dysphagia among adults with idiopathic inflammatory myopathies: a hospital-based cross-sectional study.
  17. Association of dysphagia with muscle weakness severity in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  18. Comparison of clinical and laboratory features in patients with and without dysphagia in idiopathic inflammatory myopathies: a comparative cross-sectional study.
  19. Prevalence of respiratory symptoms among adults with idiopathic inflammatory myopathies: a cross-sectional observational study.
  20. Association of respiratory symptoms with muscle strength and clinical subtype in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  21. Prevalence of restrictive spirometry pattern among adults with idiopathic inflammatory myopathies: a hospital-based cross-sectional study.
  22. Comparison of spirometry findings between polymyositis and dermatomyositis: a comparative cross-sectional study.
  23. Prevalence of electrocardiographic abnormalities among adults with idiopathic inflammatory myopathies: a cross-sectional observational study.
  24. Association of electrocardiographic abnormalities with serum muscle enzyme levels in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  25. Prevalence of anaemia among adults with idiopathic inflammatory myopathies: a hospital-based cross-sectional study.
  26. Association of haemoglobin concentration with fatigue and functional status in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  27. Relationship between erythrocyte sedimentation rate and disease activity manifestations in idiopathic inflammatory myopathies: a cross-sectional analytical study.
  28. Association of C-reactive protein concentration with extramuscular manifestations in idiopathic inflammatory myopathies: a hospital-based cross-sectional study.
  29. Pattern of antinuclear antibody positivity among adults with idiopathic inflammatory myopathies: a cross-sectional observational study.
  30. Association of myositis-specific antibody positivity with clinical phenotype in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  31. Comparison of clinical manifestations between antibody positive and antibody negative idiopathic inflammatory myopathies: a comparative cross-sectional study.
  32. Prevalence of arthritis and arthralgia among adults with idiopathic inflammatory myopathies: a cross-sectional observational study.
  33. Association of arthritis with systemic manifestations in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  34. Prevalence of Raynaud phenomenon among adults with idiopathic inflammatory myopathies: a hospital-based cross-sectional study.
  35. Association of Raynaud phenomenon with pulmonary symptoms in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  36. Prevalence of fatigue among adults with idiopathic inflammatory myopathies and associated factors: a cross-sectional observational study.
  37. Association of fatigue with muscle weakness and haemoglobin concentration in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  38. Functional disability among adults with idiopathic inflammatory myopathies and associated clinical factors: a hospital-based cross-sectional study.
  39. Association of hand grip strength with overall functional status in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  40. Nutritional status among adults with idiopathic inflammatory myopathies and its relationship with muscle strength: a cross-sectional study.
  41. Prevalence of vitamin D deficiency among adults with idiopathic inflammatory myopathies: a hospital-based cross-sectional observational study.
  42. Association of serum vitamin D concentration with muscle weakness in idiopathic inflammatory myopathies: an analytical cross-sectional study.
  43. Comparison of clinical profiles of patients receiving glucocorticoid monotherapy and combination immunosuppressive therapy for idiopathic inflammatory myopathies: a comparative cross-sectional study.
  44. Medication adherence and its association with current muscle weakness among adults with idiopathic inflammatory myopathies: a cross-sectional analytical study.
  45. Clinical, laboratory and treatment profile of idiopathic inflammatory myopathies in adults attending a tertiary care hospital: a hospital-based cross-sectional observational study.

Antineutrophil Cytoplasmic Antibody Associated Vasculitis

  1. Clinical and sociodemographic profile of adults with antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional observational study.
  2. Pattern of organ involvement among adults with antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional observational study.
  3. Comparison of clinical manifestations among major phenotypes of antineutrophil cytoplasmic antibody associated vasculitis: a comparative cross-sectional study.
  4. Association of disease duration with current organ involvement in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  5. Relationship between age at disease onset and current clinical phenotype in antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional study.
  6. Gender differences in organ involvement in antineutrophil cytoplasmic antibody associated vasculitis: a comparative cross-sectional study.
  7. Prevalence and pattern of constitutional symptoms in antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional observational study.
  8. Association of weight loss with current inflammatory markers in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  9. Prevalence and pattern of renal involvement in antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional observational study.
  10. Association of serum creatinine concentration with urinary abnormalities in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  11. Relationship between estimated glomerular filtration rate and systemic disease activity in antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional analytical study.
  12. Association of proteinuria with renal function in antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional study.
  13. Comparison of clinical profiles of patients with and without renal involvement in antineutrophil cytoplasmic antibody associated vasculitis: a comparative cross-sectional study.
  14. Prevalence of microscopic haematuria among adults with antineutrophil cytoplasmic antibody associated vasculitis and associated factors: a cross-sectional study.
  15. Prevalence of respiratory manifestations in antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional observational study.
  16. Association of respiratory symptoms with inflammatory markers in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  17. Comparison of disease characteristics in patients with and without pulmonary involvement in antineutrophil cytoplasmic antibody associated vasculitis: a comparative cross-sectional study.
  18. Prevalence of upper respiratory tract manifestations among adults with antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional observational study.
  19. Association of upper respiratory tract involvement with antibody pattern in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  20. Prevalence of neurological manifestations among adults with antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional study.
  21. Association of peripheral neuropathy with disease activity in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  22. Comparison of clinical characteristics between patients with and without peripheral neuropathy in antineutrophil cytoplasmic antibody associated vasculitis: a comparative cross-sectional study.
  23. Prevalence of cutaneous manifestations among adults with antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional observational study.
  24. Association of palpable purpura with renal involvement in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  25. Prevalence and pattern of ocular manifestations in antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional study.
  26. Association of ocular manifestations with systemic disease activity in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  27. Prevalence of musculoskeletal manifestations among adults with antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional observational study.
  28. Association of arthritis and arthralgia with inflammatory markers in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  29. Prevalence and pattern of anaemia in antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional study.
  30. Association of haemoglobin concentration with renal function in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  31. Relationship between neutrophil-to-lymphocyte ratio and disease activity in antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional analytical study.
  32. Association of platelet-to-lymphocyte ratio with systemic disease activity in antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional study.
  33. Relationship between erythrocyte sedimentation rate and disease activity in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  34. Association of C-reactive protein concentration with extent of organ involvement in antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional analytical study.
  35. Comparison of erythrocyte sedimentation rate and C-reactive protein in patients with limited and multisystem involvement: a comparative cross-sectional study.
  36. Pattern of antineutrophil cytoplasmic antibody specificity among adults with vasculitis: a cross-sectional observational study.
  37. Association of proteinase three antibody positivity with clinical phenotype in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  38. Association of myeloperoxidase antibody positivity with renal involvement in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  39. Comparison of clinical manifestations between proteinase three antibody positive and myeloperoxidase antibody positive vasculitis: a comparative cross-sectional study.
  40. Prevalence of electrolyte abnormalities among adults with renal involvement due to antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional study.
  41. Association of serum potassium concentration with renal function in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  42. Prevalence of vitamin D deficiency among adults with antineutrophil cytoplasmic antibody associated vasculitis: a hospital-based cross-sectional observational study.
  43. Association of vitamin D status with current disease activity in antineutrophil cytoplasmic antibody associated vasculitis: an analytical cross-sectional study.
  44. Medication adherence among adults receiving immunosuppressive therapy for antineutrophil cytoplasmic antibody associated vasculitis: a cross-sectional analytical study.
  45. Clinical, laboratory and treatment profile of antineutrophil cytoplasmic antibody associated vasculitis in a tertiary care medicine department: a hospital-based cross-sectional observational study.

Autoimmune Hepatitis

  1. Clinical and sociodemographic profile of adults with autoimmune hepatitis: a hospital-based cross-sectional observational study.
  2. Pattern of presenting symptoms among adults with autoimmune hepatitis: a cross-sectional observational study.
  3. Association of disease duration with current biochemical activity in autoimmune hepatitis: an analytical cross-sectional study.
  4. Relationship between age at diagnosis and current clinical manifestations in autoimmune hepatitis: a hospital-based cross-sectional study.
  5. Gender differences in clinical and biochemical characteristics of autoimmune hepatitis: a comparative cross-sectional study.
  6. Prevalence of asymptomatic biochemical abnormalities among adults with autoimmune hepatitis: a cross-sectional observational study.
  7. Association of serum alanine aminotransferase concentration with immunoglobulin G levels in autoimmune hepatitis: an analytical cross-sectional study.
  8. Relationship between serum aspartate aminotransferase concentration and bilirubin levels in autoimmune hepatitis: a cross-sectional analytical study.
  9. Association of serum bilirubin concentration with clinical severity at presentation in autoimmune hepatitis: a hospital-based cross-sectional study.
  10. Comparison of biochemical profiles of patients with and without jaundice in autoimmune hepatitis: a comparative cross-sectional study.
  11. Association of serum albumin concentration with clinical manifestations in autoimmune hepatitis: an analytical cross-sectional study.
  12. Relationship between prothrombin time abnormalities and biochemical severity of autoimmune hepatitis: a cross-sectional analytical study.
  13. Comparison of liver function parameters in patients with compensated and decompensated autoimmune hepatitis at cross-sectional assessment: a comparative cross-sectional study.
  14. Prevalence and pattern of anaemia among adults with autoimmune hepatitis: a hospital-based cross-sectional study.
  15. Association of haemoglobin concentration with severity of chronic liver dysfunction in autoimmune hepatitis: an analytical cross-sectional study.
  16. Prevalence of thrombocytopenia among adults with autoimmune hepatitis and associated clinical factors: a cross-sectional observational study.
  17. Association of platelet count with clinical evidence of portal hypertension in autoimmune hepatitis: an analytical cross-sectional study.
  18. Relationship between aspartate aminotransferase-to-platelet ratio and ultrasonographic features of chronic liver disease in autoimmune hepatitis: a cross-sectional analytical study.
  19. Association of fibrosis index based on age, aminotransferases and platelet count with ultrasonographic liver changes in autoimmune hepatitis: a hospital-based cross-sectional study.
  20. Pattern of antinuclear antibody positivity among adults with autoimmune hepatitis: a cross-sectional observational study.
  21. Association of smooth muscle antibody positivity with biochemical activity in autoimmune hepatitis: an analytical cross-sectional study.
  22. Comparison of clinical profiles between antinuclear antibody positive and smooth muscle antibody positive autoimmune hepatitis: a comparative cross-sectional study.
  23. Association of immunoglobulin G concentration with transaminase elevation in autoimmune hepatitis: an analytical cross-sectional study.
  24. Prevalence of other autoimmune diseases among adults with autoimmune hepatitis: a cross-sectional observational study.
  25. Prevalence of autoimmune thyroid disease among adults with autoimmune hepatitis: a hospital-based cross-sectional study.
  26. Comparison of autoimmune hepatitis characteristics in patients with and without autoimmune thyroid disease: a comparative cross-sectional study.
  27. Prevalence of diabetes mellitus among adults with autoimmune hepatitis and associated treatment factors: a cross-sectional study.
  28. Association of body mass index with liver enzyme abnormalities in autoimmune hepatitis: an analytical cross-sectional study.
  29. Prevalence of overweight and obesity among adults with autoimmune hepatitis: a hospital-based cross-sectional observational study.
  30. Association of metabolic syndrome with biochemical activity in autoimmune hepatitis: an analytical cross-sectional study.
  31. Comparison of biochemical profiles of autoimmune hepatitis patients with and without metabolic syndrome: a comparative cross-sectional study.
  32. Prevalence of vitamin D deficiency among adults with autoimmune hepatitis: a cross-sectional observational study.
  33. Association of serum vitamin D concentration with liver function parameters in autoimmune hepatitis: an analytical cross-sectional study.
  34. Nutritional status among adults with autoimmune hepatitis and its association with serum albumin concentration: a hospital-based cross-sectional study.
  35. Prevalence of sarcopenia risk among adults with autoimmune hepatitis using bedside screening tools: a cross-sectional observational study.
  36. Association of hand grip strength with nutritional and liver function parameters in autoimmune hepatitis: an analytical cross-sectional study.
  37. Prevalence of low bone mineral density among adults with autoimmune hepatitis: a hospital-based cross-sectional observational study.
  38. Association of glucocorticoid exposure with low bone mineral density in autoimmune hepatitis: an analytical cross-sectional study.
  39. Medication adherence among adults receiving immunosuppressive treatment for autoimmune hepatitis: a cross-sectional analytical study.
  40. Clinical, biochemical, immunological and treatment profile of autoimmune hepatitis in adults attending a tertiary care hospital: a hospital-based cross-sectional observational study.

Antiphospholipid Syndrome

  1. Clinical and sociodemographic profile of adults with antiphospholipid syndrome: a hospital-based cross-sectional observational study.
  2. Pattern of thrombotic manifestations among adults with antiphospholipid syndrome: a cross-sectional observational study.
  3. Comparison of clinical manifestations between primary and secondary antiphospholipid syndrome: a comparative cross-sectional study.
  4. Association of age with pattern of thrombosis in antiphospholipid syndrome: an analytical cross-sectional study.
  5. Gender differences in clinical manifestations of antiphospholipid syndrome: a comparative cross-sectional study.
  6. Prevalence and distribution of venous thrombosis among adults with antiphospholipid syndrome: a cross-sectional observational study.
  7. Prevalence and distribution of arterial thrombosis among adults with antiphospholipid syndrome: a hospital-based cross-sectional study.
  8. Comparison of clinical characteristics of patients with arterial and venous thrombosis in antiphospholipid syndrome: a comparative cross-sectional study.
  9. Association of recurrent thrombotic history with antiphospholipid antibody profile: an analytical cross-sectional study.
  10. Prevalence of thrombocytopenia among adults with antiphospholipid syndrome: a cross-sectional observational study.
  11. Association of thrombocytopenia with antiphospholipid antibody profile: an analytical cross-sectional study.
  12. Comparison of clinical manifestations between antiphospholipid syndrome patients with and without thrombocytopenia: a comparative cross-sectional study.
  13. Prevalence and pattern of anaemia among adults with antiphospholipid syndrome: a hospital-based cross-sectional study.
  14. Association of haemoglobin concentration with current clinical manifestations in antiphospholipid syndrome: an analytical cross-sectional study.
  15. Prevalence of livedo reticularis among adults with antiphospholipid syndrome and associated antibody profiles: a cross-sectional study.
  16. Association of cutaneous manifestations with arterial thrombosis in antiphospholipid syndrome: an analytical cross-sectional study.
  17. Prevalence of neurological manifestations among adults with antiphospholipid syndrome: a hospital-based cross-sectional observational study.
  18. Comparison of antiphospholipid antibody profiles in patients with and without neurological manifestations: a comparative cross-sectional study.
  19. Prevalence of cardiac manifestations among adults with antiphospholipid syndrome: a cross-sectional observational study.
  20. Association of electrocardiographic abnormalities with thrombotic phenotype in antiphospholipid syndrome: an analytical cross-sectional study.
  21. Prevalence of renal abnormalities among adults with antiphospholipid syndrome: a hospital-based cross-sectional study.
  22. Association of renal involvement with hypertension in antiphospholipid syndrome: an analytical cross-sectional study.
  23. Pattern of lupus anticoagulant positivity among adults with antiphospholipid syndrome: a cross-sectional observational study.
  24. Association of lupus anticoagulant positivity with venous thrombosis in antiphospholipid syndrome: an analytical cross-sectional study.
  25. Association of anticardiolipin antibody positivity with arterial thrombosis in antiphospholipid syndrome: a cross-sectional analytical study.
  26. Association of anti-beta-two glycoprotein one antibody positivity with thrombotic manifestations in antiphospholipid syndrome: an analytical cross-sectional study.
  27. Comparison of clinical manifestations among patients with single, double and triple antiphospholipid antibody positivity: a comparative cross-sectional study.
  28. Prevalence of conventional cardiovascular risk factors among adults with antiphospholipid syndrome: a cross-sectional observational study.
  29. Association of dyslipidaemia with arterial thrombosis in antiphospholipid syndrome: an analytical cross-sectional study.
  30. Prevalence of hypertension among adults with antiphospholipid syndrome and associated thrombotic characteristics: a hospital-based cross-sectional study.
  31. Association of body mass index with venous thrombotic manifestations in antiphospholipid syndrome: an analytical cross-sectional study.
  32. Prevalence of smoking and tobacco use among adults with antiphospholipid syndrome: a cross-sectional observational study.
  33. Association of smoking with arterial thrombotic manifestations in antiphospholipid syndrome: an analytical cross-sectional study.
  34. Comparison of clinical profiles of primary antiphospholipid syndrome and antiphospholipid syndrome associated with systemic lupus erythematosus: a comparative cross-sectional study.
  35. Association of complement concentrations with clinical manifestations in antiphospholipid syndrome associated with systemic lupus erythematosus: an analytical cross-sectional study.
  36. Prevalence and pattern of obstetric morbidity among women with antiphospholipid syndrome: a cross-sectional observational study.
  37. Association of antiphospholipid antibody profile with previous obstetric morbidity in women with antiphospholipid syndrome: an analytical cross-sectional study.
  38. Comparison of antibody profiles in thrombotic and obstetric antiphospholipid syndrome: a comparative cross-sectional study.
  39. Anticoagulant treatment patterns and current coagulation parameters among adults with antiphospholipid syndrome: a cross-sectional observational study.
  40. Clinical, laboratory and treatment profile of adults with antiphospholipid syndrome attending a tertiary care medicine department: a hospital-based cross-sectional observational study.

Mixed Connective Tissue Disease

  1. Clinical and sociodemographic profile of adults with mixed connective tissue disease: a hospital-based cross-sectional observational study.
  2. Pattern of organ involvement among adults with mixed connective tissue disease: a cross-sectional observational study.
  3. Association of disease duration with current organ involvement in mixed connective tissue disease: an analytical cross-sectional study.
  4. Relationship between age at disease onset and current clinical manifestations in mixed connective tissue disease: a hospital-based cross-sectional study.
  5. Gender differences in clinical manifestations of mixed connective tissue disease: a comparative cross-sectional study.
  6. Prevalence and severity of Raynaud phenomenon among adults with mixed connective tissue disease: a cross-sectional observational study.
  7. Association of Raynaud phenomenon severity with digital changes in mixed connective tissue disease: an analytical cross-sectional study.
  8. Prevalence of swollen hands and hand oedema among adults with mixed connective tissue disease: a hospital-based cross-sectional study.
  9. Association of hand swelling with inflammatory markers in mixed connective tissue disease: an analytical cross-sectional study.
  10. Prevalence and pattern of arthritis among adults with mixed connective tissue disease: a cross-sectional observational study.
  11. Association of arthritis with disease activity manifestations in mixed connective tissue disease: an analytical cross-sectional study.
  12. Prevalence of muscle weakness among adults with mixed connective tissue disease: a hospital-based cross-sectional study.
  13. Association of serum creatine kinase concentration with muscle weakness in mixed connective tissue disease: an analytical cross-sectional study.
  14. Comparison of clinical characteristics between mixed connective tissue disease patients with and without muscle involvement: a comparative cross-sectional study.
  15. Prevalence of respiratory symptoms among adults with mixed connective tissue disease: a cross-sectional observational study.
  16. Association of exertional dyspnoea with disease duration in mixed connective tissue disease: an analytical cross-sectional study.
  17. Prevalence of restrictive spirometry pattern among adults with mixed connective tissue disease: a hospital-based cross-sectional study.
  18. Comparison of clinical profiles of mixed connective tissue disease patients with and without respiratory manifestations: a comparative cross-sectional study.
  19. Prevalence of gastrointestinal symptoms among adults with mixed connective tissue disease: a cross-sectional observational study.
  20. Association of dysphagia with disease duration and systemic manifestations in mixed connective tissue disease: an analytical cross-sectional study.
  21. Prevalence and pattern of anaemia among adults with mixed connective tissue disease: a hospital-based cross-sectional study.
  22. Association of haemoglobin concentration with fatigue and functional status in mixed connective tissue disease: an analytical cross-sectional study.
  23. Relationship between erythrocyte sedimentation rate and systemic manifestations in mixed connective tissue disease: a cross-sectional analytical study.
  24. Association of C-reactive protein concentration with musculoskeletal manifestations in mixed connective tissue disease: a hospital-based cross-sectional study.
  25. Association of anti-U1 ribonucleoprotein antibody titre with clinical manifestations of mixed connective tissue disease: an analytical cross-sectional study.
  26. Prevalence of thyroid dysfunction among adults with mixed connective tissue disease: a cross-sectional observational study.
  27. Prevalence of vitamin D deficiency among adults with mixed connective tissue disease and its association with disease manifestations: a cross-sectional study.
  28. Fatigue and health-related quality of life among adults with mixed connective tissue disease: a hospital-based cross-sectional observational study.
  29. Medication adherence and its association with current disease activity manifestations in mixed connective tissue disease: an analytical cross-sectional study.
  30. Clinical, laboratory, immunological and treatment profile of adults with mixed connective tissue disease attending a tertiary care hospital in India: a hospital-based cross-sectional observational study.

Not the general medicine subspeciality you need? Autoimmune diseases is one section of our full general medicine collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.

Browse all General Medicine Thesis Topics →

📌 Updated for 2026–2027 MD Medicine/DNB Medicine Autoimmune Diseases admissions

The page has been reviewed for feasibility in postgraduate medicine departments where most autoimmune-disease research can be completed with structured phenotyping, routine inflammatory markers, antibody profiles and clinically indicated organ assessment.

  • Most projects can be completed with complete blood counts, ESR, C-reactive protein, renal and liver tests, urinalysis, autoantibodies, thyroid tests, functional scales and routinely indicated cardiopulmonary or imaging investigations.
  • Research-only cytokine panels, expensive molecular assays, serial advanced imaging and specialised immunophenotyping are not required for most practical dissertation designs.
  • Publication potential is strongest when classification criteria, activity measures, treatment exposure and organ-involvement definitions are prespecified before recruitment.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full autoimmune diseases protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside autoimmune diseases protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Autoimmune diseases research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the autoimmune diseases research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the autoimmune diseases research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare an autoimmune diseases research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A autoimmune diseases IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning autoimmune diseases research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the autoimmune diseases research proposal is the document assessed at the start of it.

Kuwait — KIMS. A autoimmune diseases study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the autoimmune diseases proposal follows the same structure throughout.

Generate an autoimmune diseases research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A autoimmune diseases dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full autoimmune diseases research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about an autoimmune diseases PhD or MMed proposal →

🔥 Trending research areas in Autoimmune Diseases for 2026–27

Current dissertation opportunities increasingly focus on phenotype precision, treatment-related comorbidity and early organ involvement rather than descriptive antibody or symptom profiles alone.

  • Disease activity versus damage: rheumatoid arthritis, systemic lupus erythematosus and vasculitis offer useful projects when active inflammation is separated from fixed deformity, fibrosis or chronic organ damage.
  • Cardiometabolic and treatment burden: obesity, dyslipidaemia, diabetes, bone health and cardiovascular risk can be studied when glucocorticoid exposure and immunosuppressive treatment are recorded as major confounders.
  • Organ-dominant autoimmune phenotypes: renal, pulmonary, neurological, hepatic and vascular involvement provide clinically useful endpoints when objective definitions replace symptom-only classification.
  • Overlap and associated autoimmunity: mixed connective tissue disease, Sjögren overlap, autoimmune thyroid associations and antiphospholipid manifestations are increasingly useful when classification criteria and antibody interpretation are standardised.

Protocol and synopsis guidance

What an Autoimmune Diseases protocol must contain

Classification criteria: State the criteria used to classify the autoimmune disease being studied. A previous chart label or isolated antibody positivity should not be the sole basis for inclusion when clinical phenotypes overlap.

Activity, damage and function: Disease activity, irreversible organ damage and functional limitation are different constructs. The protocol should name the instrument used for each and avoid treating chronic damage as active inflammation.

Treatment exposure: Glucocorticoids, disease-modifying antirheumatic drugs, immunosuppressants and thyroid replacement or antithyroid therapy can alter inflammatory markers, blood counts, metabolic variables and organ manifestations. Current treatment, dose and duration should be recorded where relevant.

Laboratory interpretation: Autoantibody positivity may assist diagnosis or phenotype classification but does not automatically represent current activity. ESR, C-reactive protein, complement, antibody titres and routine blood-cell indices should be interpreted within the disease and treatment context.

Avoid circular analysis: If ESR, C-reactive protein, complement, proteinuria, joint counts or another variable already contributes to the chosen activity score, testing that same variable as an independent predictor of the score creates a built-in association.

Autoimmune Diseases synopsis versus Autoimmune Diseases protocol

Synopsis: The synopsis should state the autoimmune disease, study design, principal exposure or biomarker, activity or organ outcome, approximate sample size and broad statistical plan in a concise form suitable for academic review.

Protocol: The full protocol must define classification criteria, activity and damage instruments, treatment exposure, timing of laboratory measurements, antibody interpretation, organ-involvement definitions, imaging or physiological reference standards and handling of overlap syndromes.

Why the distinction matters: A synopsis may propose studying complement levels in systemic lupus erythematosus activity, but the protocol must specify the activity score, whether complement is already part of that score, the timing of sampling relative to treatment and whether the analysis is intended to show independent association or only agreement with an activity component.

Sample size and statistical analysis

Base the calculation on the primary objective: Estimating anaemia prevalence, comparing antibody-defined phenotypes, correlating a biomarker with functional limitation and evaluating predictors of renal or vascular involvement require different sample-size assumptions.

Avoid component-versus-composite testing: A laboratory value or clinical finding already contained within a disease-activity score should not be treated as an independent predictor of that same total score without acknowledging the mathematical dependence.

Control treatment-related confounding: Glucocorticoid exposure, immunosuppressive therapy, disease duration, body mass index, age and comorbidity can affect metabolic, cardiovascular, bone, infectious and laboratory outcomes.

Respect ordinal and repeated measures: Activity categories, functional classes and organ-severity grades may be ordinal, while laboratory values may be measured repeatedly. Statistical methods should match the scale and timing of the data rather than treating every measurement as an independent continuous variable.

Frequently Asked Questions – Autoimmune Diseases Research Topics (2026–27)

1. How do I choose a feasible Autoimmune Diseases topic for the 2026–2027 academic year?

Start with an autoimmune condition that your medicine service sees often enough to recruit within the planned data-collection period. Rheumatoid arthritis, systemic lupus erythematosus, autoimmune thyroid disease and common systemic manifestations usually provide more practical recruitment than rare overlap syndromes. Prefer one primary domain such as disease activity, functional disability, renal involvement, cardiometabolic risk or treatment-related abnormality.

2. Which study designs are usually accepted for an Autoimmune Diseases dissertation?

Feasible designs include cross-sectional observational and analytical studies, comparative studies between clearly defined phenotypes, retrospective record-based cohorts, short prospective cohorts and studies of organ involvement using a predefined clinical, imaging or physiological reference standard. The design should follow the research question rather than defaulting to a cross-sectional label.

3. What should I settle with my guide before finalising an Autoimmune Diseases topic?

Agree on the exact classification criteria, activity or functional instrument, primary outcome, treatment variables, required antibody tests, organ-involvement definition and expected case load. Decide in advance how overlap syndromes, antibody-negative disease and patients already receiving immunosuppressive treatment will be handled.

4. Can I use routine autoantibody and inflammatory-marker results for my Autoimmune Diseases thesis?

Yes, provided their role is defined correctly. ESR and C-reactive protein are non-specific and may be influenced by infection, anaemia, obesity and treatment. Autoantibody positivity may support diagnosis or phenotype definition but does not automatically measure current disease activity. The protocol should distinguish diagnostic, activity-related and prognostic use of each test.

5. What is the difference between an Autoimmune Diseases synopsis and an Autoimmune Diseases protocol?

The synopsis presents the research question, autoimmune-disease population, study design, principal variables and broad analysis plan. The protocol converts that idea into a reproducible method by defining classification criteria, activity and damage instruments, treatment exposure, laboratory timing, antibody interpretation, organ-involvement criteria, sample-size assumptions and statistical analysis.

6. What ethical issues should I address in an Autoimmune Diseases study?

Prospective studies should obtain informed consent, while approved retrospective record-based work may qualify for a waiver of consent. If children are included, guardian consent and child assent from about seven years should be addressed. No additional radiation, contrast study, biopsy, invasive vascular investigation or research-only venepuncture should be added merely for the dissertation unless scientifically justified and approved. If extra blood is required, the protocol should state the blood-volume limit.

Separate consent is required for identifiable photographs or video of skin, joint, gait or neurological findings. Incidental clinically important abnormalities such as severe renal dysfunction, major cytopenia, pulmonary involvement, thrombosis, significant liver dysfunction or possible malignancy should have a named escalation pathway to the treating team. Imaging datasets should be anonymised before research use.

7. How do I avoid circular associations when studying Autoimmune Diseases activity?

Inspect every component of the activity measure before choosing predictors. If ESR, C-reactive protein, complement, proteinuria, joint counts or another variable already contributes to the total activity score, a significant association with that score may be partly mathematical rather than biologically independent. Use an external outcome such as functional disability, objectively defined organ involvement or a different score that does not contain the proposed predictor, or clearly describe the analysis as a study of score components.

8. Can an Autoimmune Diseases dissertation later support a PhD or Gulf board research pathway?

Yes, but the documents serve different purposes. An MD or DNB synopsis is usually a bounded residency dissertation plan, while a PhD proposal generally requires a broader research gap, more extensive methodology and a programme of work beyond one residency project. Gulf pathways may also require a separate board research project under SCFHS and the Saudi Board, the Arab Board, or DHP, DHA, DOH and MOHAP-linked training programmes. The same autoimmune-disease question can sometimes be adapted, but supervision, ethics, format and institutional requirements should be checked for the specific programme.

9. When should I register my Autoimmune Diseases dissertation?

Register after the classification criteria, activity or organ outcome, primary predictor, sample-size basis and expected recruitment rate have been agreed with the guide. Confirm that the required antibody tests, imaging, pulmonary function testing, thyroid investigations or other organ-specific assessments are available consistently before final registration.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol
Don`t copy text!
Generate Thesis Protocol / Synopsis
×